Oxybutynin Chloride
Product Images NDC 10544-559

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 10544-559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 5mg 90ct (Label Oxybutynin Chloride Tabs 5mg Bpi(10544 559 90) Teva(50111 456 03) Rev2)

This is a product description for Oxybutynin Chloride Tablets, USP 5mg. The tablets come in a package of 90 and are only available through a prescription. The recommended dosage is found in the package insert. The tablets should be stored at a controlled room temperature between 20-25°C (68°-77°F) in a container that is opaque and resistant to light. Each tablet contains Oxybutynin Chloride, USP. The tablets are manufactured by Teva Pharmaceuticals USA in NY, and the lot number is BPO000000D. The product is packaged by Blenheim Pharmacal, Inc., and the expiration date is 00/0010000. The remaining text contains duplicate information.*

FDA Label Image

Oxybutynin Structural Formula (F31ecbfd 0404 4601 9887 14dbba9cb7ce 01)

FDA Label Image

Figure 1 (F31ecbfd 0404 4601 9887 14dbba9cb7ce 02)

This is a prescription for oxybutynin, 5mg taken three times a day. It appears to be accompanied by a graph with time (in hours) on the x-axis and some values on the y-axis. However, the content of the graph is not clear due to poor readability.*

FDA Label Image

Figure 2 Mean Steady-state (F31ecbfd 0404 4601 9887 14dbba9cb7ce 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.